¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ ,L/x\_28  
Z4] n<~o  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© CFaY=Cy  
9-ozrw 8t  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© ntW@Fm:bw>  
ShB]U5b:k  
1.Co-stimulators (or co-stimulating molecules) po*G`b;v  
Jxe+LG  
2.NK-kB c5YPV"X  
V_+&Y$msi~  
3.Immunoglobulin superfamily cSb;a\el$  
Kw -SOFE  
4.antigen-presenting cell (APC) isZ5s \  
8`q7Yss6F  
5.death domain vi,hWz8WB  
_wq?Pa<)e  
6.CCR and CXCR H71sxek3  
qlO}=b/  
7.Lectin (or mitogen) ks4`h>i  
Y2H-D{a27  
8.Clusters of differentiation, CD) CXlbtpK2k  
d!,t_jM0  
9.B7 family 2B,O/3y  
{K,In)4  
10.Cytotoxic T lymphocyte, CTL) ;P@]7vkff  
5~*)3z^V  
11.IL-15 and IL-15 receptor (IL-15R) ^jdU4  
~3&{`9Y  
12.MHC restriction :D.0\.p  
&gXh:.  
13.Affinity-chromatography Fhoyji4  
Yd^@Ei9  
14.Cyctosprin A, CsA )pnyVTKt  
)#=J<OpG  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) Gz[yD ~6a  
.Eao|;  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© HgI!q<)  
ccD+AGM.  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 ._mep\#.:  
.HqFdsm  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ {@Mr7*u  
wX$:NOO  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ s{hKl0ds  
2-&EkF4p'  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© ' W/M>!X  
@f!X%)\;x  
ÃâÒßѧרҵ£º op,L3:R\Z  
QTV*m>D  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ eI #Gx_mg  
=OVDJ0ozZ  
Ïû»¯ÄÚ¿Æ£º x&}]8S)  
6*OL.~WE  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ l'@-?p(Vuw  
cNs'GfD}  
ѪҺ²¡Ñ§×¨Òµ£º RaZ>.5 D  
c\bL_  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
4+6=? ÕýÈ·´ð°¸:10
°´"Ctrl+Enter"Ö±½ÓÌá½»